Search

Substrate sustained release-based high efficacy biosynthesis of GABA by Lactobacillus brevis NCL912

메타 데이터

바이오화학분류
    • 바이오플라스틱
      1. 기타
    • 바이오정밀화학
      1. 기타
    • 의료용 화학소재
      1. 식품첨가제
논문

Substrate sustained release-based high efficacy biosynthesis of GABA by Lactobacillus brevis NCL912

학술지

Microbial cell factories

저자명

Wang, Qiong; Liu, Xiaohua; Fu, Jinheng; Wang, Shuixing; Chen, Yuanhong; Chang, Kunpeng; Li, Haixing

초록

<P><B>Background</B></P><P>Gamma-aminobutyric acid (GABA) plays a significant role in the food and drug industries. Our previous study established an efficient fed-batch fermentation process for <I>Lactobacillus brevis</I> NCL912 production of GABA from monosodium <SMALL>L</SMALL>-glutamate; however, monosodium <SMALL>L</SMALL>-glutamate may not be an ideal substrate, as it can result in the rapid increase of pH due to decarboxylation. Thus, in this study, <SMALL>L</SMALL>-glutamic acid was proposed as a substrate. To evaluate its potential, key components of the fermentation medium affecting GABA synthesis were re-screened and re-optimized to enhance GABA production from <I>L. brevis</I> NCL912.</P><P><B>Results</B></P><P>The initial fermentation medium (pH 3.3) used for optimization was: 50&nbsp;g/L glucose, 25&nbsp;g/L yeast extract, 10&nbsp;mg/L manganese sulfate (MnSO<SUB>4</SUB>·H<SUB>2</SUB>O), 2&nbsp;g/L Tween-80, and 220&nbsp;g/L <SMALL>L</SMALL>-glutamic acid. Glucose, a nitrogen source, magnesium, and Tween-80 had notable effects on GABA production from the <SMALL>L</SMALL>-glutamic acid-based process; other factors showed no or marginal effects. The optimized levels of the four key components in the fermentation medium were 25&nbsp;g/L glucose, 25&nbsp;g/L yeast extract FM408, 25&nbsp;mg/L MnSO<SUB>4</SUB>·H<SUB>2</SUB>O, and 2&nbsp;g/L Tween-80. A simple and efficient fermentation process for the bioconversion of GABA by <I>L. brevis</I> NCL912 was subsequently developed in a 10&nbsp;L fermenter as follows: fermentation medium, 5&nbsp;L; glutamic acid, 295&nbsp;g/L; inoculum, 10% (v/v); incubation temperature, 32&nbsp;°C; and agitation, 100&nbsp;rpm. After 48&nbsp;h of fermentation, the final GABA concentration increased up to 205.8 ± 8.0&nbsp;g/L.</P><P><B>Conclusions</B></P><P><SMALL>L</SMALL>-Glutamic acid was superior to monosodium <SMALL>L</SMALL>-glutamate as a substrate in the bioproduction of GABA. Thus, a high efficacy bioprocess with 205&nbsp;g/L GABA for <I>L. brevis</I> NCL912 was established. This strategy may provide an alternative for increasing the bioconversion of GABA.</P>

발행연도

2018

발행기관

BioMed Central

라이선스

cc-by

ISSN

1475-2859

17

페이지

pp.80

주제어

Lactobacillus brevis NCL912; Sustained release of L-glutamic acid; pH self-control of L-glutamic acid; Gamma-aminobutyric acid

0건의 논문이 있습니다.

0건의 특허가 있습니다.

0건의 무역이 있습니다.

1건의 후보군 물질이 있습니다.

1 2023-12-11

논문; 2018-05-19

Export

About

Search

Trend